Family Medicine · Irwin, PA
NPI
1093713968
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
905 Spruce St, Suite 201
Irwin, PA, 15642
Phone (724) 864-9595
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
1,349 services
Medicare patients, 2024
352
Average age 76
Drug cost, 2024
$2.0M
21,679 prescriptions
Company payments, 2025
$2,369
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark C Gottron was code 99310 (snf e&m), 471 times for 103 patients. In total Mark C Gottron billed 1,349 services in 38 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99310 SNF E&M | Facility | 471 | 103 | $114.05 | $54K |
| 99213 Office E&M - Established | Office | 218 | 143 | $56.13 | $12K |
| 99214 Office E&M - Established | Office | 131 | 89 | $76.01 | $9,958 |
| 99306 SNF E&M | Facility | 86 | 84 | $134.79 | $12K |
| 99497 Care Management/Coordination | Facility | 82 | 81 | $56.87 | $4,663 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 69 | 69 | $122.65 | $8,463 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 62 | 62 | $17.65 | $1,094 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 21 | 19 | $9.26 | $195 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $29.93 | $449 |
| 90653 Vaccine Product | Office | 12 | 12 | $81.82 | $982 |
| 99203 Office E&M - New | Office | 11 | 11 | $61.15 | $673 |
By year: 2022 $62K for 1,098 services; 2023 $76K for 1,060 services; 2024 $110K for 1,349 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark C Gottron prescribed most often to Medicare patients was Levothyroxine Sodium, with 877 prescriptions and refills. In total Mark C Gottron wrote 21,679 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 877 | 1,810 | 192 | $8,838 |
| Atorvastatin Calcium Generic | 857 | 2,021 | 231 | $9,819 |
| Pantoprazole Sodium Generic | 664 | 1,535 | 174 | $8,428 |
| Amlodipine Besylate Generic | 545 | 1,311 | 145 | $3,270 |
| Lisinopril Generic | 500 | 1,242 | 137 | $3,695 |
| Eliquis Apixaban | 476 | 626 | 103 | $301K |
| Omeprazole Generic | 458 | 817 | 126 | $4,187 |
| Simvastatin Generic | 435 | 1,016 | 105 | $4,325 |
| Metoprolol Tartrate Generic | 429 | 842 | 97 | $2,927 |
| Losartan Potassium Generic | 420 | 1,109 | 118 | $4,841 |
| Duloxetine Hcl Generic | 369 | 730 | 81 | $5,393 |
| Furosemide Generic | 345 | 547 | 114 | $1,235 |
| Metformin Hcl Generic | 339 | 841 | 94 | $2,012 |
| Hydrochlorothiazide Generic | 328 | 807 | 90 | $1,592 |
| Potassium Chloride Generic | 321 | 552 | 88 | $9,096 |
Brand drugs: 3,061 claims; generic drugs: 18,395 claims; opioid claims: 270.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark C Gottron $2,369 ($2,369 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $349.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 20 | $349 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $262 |
| Lilly USA, LLC LLY | 16 | $253 |
| Abbvie Inc. ABBV | 19 | $203 |
| Pfizer Inc. PFE | 14 | $194 |
| Shockwave Medical, Inc JNJ | 1 | $171 |
| Abbott Laboratories ABT | 2 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $125 |
| GlaxoSmithKline, LLC. GSK | 5 | $90.42 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $80.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.